Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment

Antonella Vigani, Maria Pia Pistillo, Vincenzo Fontana, Ugo Giannoni, Ilan Rosenberg, Pier Aldo Canessa, Giovanni Berisso, Paola Ferro, Maria Cristiana Franceschini, Marika Tonarelli, Silvio Roncella

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e143-e145
JournalJournal of Thoracic Oncology
Volume13
Issue number8
DOIs
Publication statusPublished - Aug 1 2018

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Vigani, A., Pistillo, M. P., Fontana, V., Giannoni, U., Rosenberg, I., Canessa, P. A., Berisso, G., Ferro, P., Franceschini, M. C., Tonarelli, M., & Roncella, S. (2018). Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment. Journal of Thoracic Oncology, 13(8), e143-e145. https://doi.org/10.1016/j.jtho.2018.03.015